EP3880184A4 - Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage - Google Patents

Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage Download PDF

Info

Publication number
EP3880184A4
EP3880184A4 EP19884098.5A EP19884098A EP3880184A4 EP 3880184 A4 EP3880184 A4 EP 3880184A4 EP 19884098 A EP19884098 A EP 19884098A EP 3880184 A4 EP3880184 A4 EP 3880184A4
Authority
EP
European Patent Office
Prior art keywords
vape
cannabinoid
manufacturing
oil including
vape device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19884098.5A
Other languages
German (de)
English (en)
Other versions
EP3880184A1 (fr
Inventor
Max Alsayar
Patrick Woods
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexo Operations Inc
Original Assignee
Hexo Operations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA3024052A external-priority patent/CA3024052A1/fr
Priority claimed from CA3024431A external-priority patent/CA3024431C/fr
Priority claimed from CA3024645A external-priority patent/CA3024645A1/fr
Application filed by Hexo Operations Inc filed Critical Hexo Operations Inc
Publication of EP3880184A1 publication Critical patent/EP3880184A1/fr
Publication of EP3880184A4 publication Critical patent/EP3880184A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/42—Cartridges or containers for inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19884098.5A 2018-11-13 2019-11-13 Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage Withdrawn EP3880184A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA3024052A CA3024052A1 (fr) 2018-11-13 2018-11-13 Huile de cannabis pour vapotage et methode d`utilisation et de fabrication
CA3024431A CA3024431C (fr) 2018-11-15 2018-11-15 Huile de cannabis pour vapotage, methode d'utilisation et de fabrication associee
CA3024645A CA3024645A1 (fr) 2018-11-19 2018-11-19 Huile de cannabis a haute teneur en cannabinoide destinee au vapotage, methode d'utilisation et de fabrication associee
PCT/CA2019/051618 WO2020097726A1 (fr) 2018-11-13 2019-11-13 Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage

Publications (2)

Publication Number Publication Date
EP3880184A1 EP3880184A1 (fr) 2021-09-22
EP3880184A4 true EP3880184A4 (fr) 2022-09-28

Family

ID=70731038

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19884098.5A Withdrawn EP3880184A4 (fr) 2018-11-13 2019-11-13 Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage

Country Status (4)

Country Link
US (1) US20200297025A1 (fr)
EP (1) EP3880184A4 (fr)
CA (1) CA3119204A1 (fr)
WO (1) WO2020097726A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220211660A1 (en) * 2020-10-24 2022-07-07 Mason Cave High viscosity thc product and method of manufacture thereof
WO2022232574A1 (fr) * 2021-04-29 2022-11-03 Tilray, Inc. Formulations dans lesquelles le cannabidiol est le constituant dominant, leurs procédés de fabrication et leurs utilisations
US20220378104A1 (en) * 2021-05-28 2022-12-01 Shenzhen Eigate Technology Co., Ltd. Atomizer and electronic cigarette comrpising the same
GB202110543D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
WO2024113046A1 (fr) * 2022-11-28 2024-06-06 Zest Cannabis Inc. Compositions de cannabinoïde vaporisables

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015116463A1 (fr) * 2013-01-30 2015-08-06 Larson Raymond Louis Thc sans fumée et son procédé d'administration
US20160136213A1 (en) * 2014-11-14 2016-05-19 Charles William Paul Process to suspend cannabis oil in glycerin
US20160309774A1 (en) * 2015-04-27 2016-10-27 Michael D. Wand Terpene carrier
US20170119040A1 (en) * 2015-10-30 2017-05-04 Lunatech, Llc Water-based vaporizable liquids, methods and systems for vaporizing same
US9744200B1 (en) * 2017-01-19 2017-08-29 Oak and Crane, LLC System for producing a terpene-enhanced cannabinoid concentrate
WO2018113888A1 (fr) * 2016-12-22 2018-06-28 Medcan Pharma A/S Composition de cannabinoïde liquide
US10034907B1 (en) * 2017-04-07 2018-07-31 Gerald Echavarry Flavored and edible cannabinoid composition and method of manufacturing
US20180221333A1 (en) * 2017-03-22 2018-08-09 Rise Research Inc Optimized cannabis-based aphrodisiac and mood enhancer
WO2018152637A1 (fr) * 2017-02-22 2018-08-30 Gene Bernaudo Systèmes de composition d'agent de mélange de cigarettes électroniques
WO2018173049A1 (fr) * 2017-03-20 2018-09-27 Kanabo Research Ltd. Compositions vaporisables comprenant du cannabinol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2974292C (fr) * 2015-01-31 2024-04-16 Constance Therapeutics, Inc. Procedes de preparation d'extraits d'huile de cannabis et compositions
AU2016359160A1 (en) * 2015-11-24 2018-06-14 Constance Therapeutics, Inc. Cannabis oil compositions and methods for preparation thereof

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015116463A1 (fr) * 2013-01-30 2015-08-06 Larson Raymond Louis Thc sans fumée et son procédé d'administration
US20160136213A1 (en) * 2014-11-14 2016-05-19 Charles William Paul Process to suspend cannabis oil in glycerin
US20160309774A1 (en) * 2015-04-27 2016-10-27 Michael D. Wand Terpene carrier
US20170119040A1 (en) * 2015-10-30 2017-05-04 Lunatech, Llc Water-based vaporizable liquids, methods and systems for vaporizing same
WO2018113888A1 (fr) * 2016-12-22 2018-06-28 Medcan Pharma A/S Composition de cannabinoïde liquide
US9744200B1 (en) * 2017-01-19 2017-08-29 Oak and Crane, LLC System for producing a terpene-enhanced cannabinoid concentrate
WO2018152637A1 (fr) * 2017-02-22 2018-08-30 Gene Bernaudo Systèmes de composition d'agent de mélange de cigarettes électroniques
WO2018173049A1 (fr) * 2017-03-20 2018-09-27 Kanabo Research Ltd. Compositions vaporisables comprenant du cannabinol
US20180221333A1 (en) * 2017-03-22 2018-08-09 Rise Research Inc Optimized cannabis-based aphrodisiac and mood enhancer
US10034907B1 (en) * 2017-04-07 2018-07-31 Gerald Echavarry Flavored and edible cannabinoid composition and method of manufacturing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020097726A1 *

Also Published As

Publication number Publication date
US20200297025A1 (en) 2020-09-24
WO2020097726A1 (fr) 2020-05-22
CA3119204A1 (fr) 2020-05-22
EP3880184A1 (fr) 2021-09-22

Similar Documents

Publication Publication Date Title
EP3880184A4 (fr) Procédé de fabrication d'huile de vapotage comprenant un cannabinoïde destiné à être utilisé dans un dispositif de vapotage
EP3902292A4 (fr) Procédé de positionnement, et dispositif associé
EP3581890B8 (fr) Procédé et dispositif de positionnement
EP3742829A4 (fr) Procédé de positionnement, et dispositif associé
EP3598492A4 (fr) Procédé de fabrication de dispositif d'affichage
EP3855494A4 (fr) Dispositif d'affichage et son procédé de fabrication
EP3896734A4 (fr) Dispositif d'affichage et son procédé de fabrication
EP3902002A4 (fr) Dispositif d'affichage et son procédé de fabrication
EP3499085A4 (fr) Dispositif cylindre et procédé de fabrication de dispositif cylindre
EP3855496A4 (fr) Dispositif d'affichage et son procédé de fabrication
EP3836217A4 (fr) Dispositif d'affichage et son procédé de fabrication
EP3573349A4 (fr) Transducteur et son procédé de fabrication
EP3605627A4 (fr) Dispositif piézoélectrique et procédé de fabrication de dispositif piézoélectrique
EP3657923A4 (fr) Procédé de fabrication de dispositif électronique
EP3404862A4 (fr) Procédé et dispositif de transmission par pbch à bande étroite
EP3292534A4 (fr) Procédé et dispositif d'estimation du risque de rechute d'un comportement addictif
EP3668115A4 (fr) Transducteur et son procédé de fabrication
EP3892605A4 (fr) Dispositif de production d'ydrocarbures et procédé de production d'hydrocarbures
EP3892603A4 (fr) Dispositif de production d'hydrocarbures et procédé de production d'hydrocarbures
EP3780072A4 (fr) Procédé de fabrication de dispositif électronique
EP3686666A4 (fr) Procédé de fabrication de dispositif électrochromique
EP3657532A4 (fr) Procédé de fabrication de dispositif électronique
EP3855311A4 (fr) Procédé et dispositif de démarrage d'application
EP3903663A4 (fr) Dispositif de mesure de propriété de réfraction, outil de mesure et procédé de mesure de propriété de réfraction
EP3786301A4 (fr) Huile microbienne et procédé de production d'huile microbienne

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210611

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220826

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20220822BHEP

Ipc: A61K 47/10 20170101ALI20220822BHEP

Ipc: A61K 47/14 20170101ALI20220822BHEP

Ipc: A61M 15/06 20060101ALI20220822BHEP

Ipc: C07D 311/80 20060101ALI20220822BHEP

Ipc: C07C 39/23 20060101ALI20220822BHEP

Ipc: B05B 1/24 20060101ALI20220822BHEP

Ipc: A61K 47/44 20170101ALI20220822BHEP

Ipc: A61K 31/352 20060101ALI20220822BHEP

Ipc: A61K 31/05 20060101ALI20220822BHEP

Ipc: A24D 1/18 20060101ALI20220822BHEP

Ipc: A61K 9/72 20060101AFI20220822BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230324